Text Theme
Note

Education, not medical advice. Tests and their interpretation belong with your own clinician.

Diagnostic · Vascular

Endothelial biomarkers and flow-mediated dilation

If the vessel lining is injured in long COVID, can we measure it? Tests like flow-mediated dilation and circulating endothelial cell counts probe exactly that, and they show abnormalities, but they remain research tools rather than something that changes a clinic visit today.

Short version: endothelial tests (flow-mediated dilation, circulating endothelial cells) show vessel-lining injury in long COVID, but they are research-grade and not yet validated to guide individual care.

Measuring the vessel lining

Because vessel-lining injury is central to long COVID, tests that probe it are of interest: flow-mediated dilation (an ultrasound of how an artery widens), counts of circulating endothelial cells shed into the blood, and markers of clotting and inflammation.1

Healthy: ACE2 keeps the balance ACE2 converts angiotensin II into the protective, vessel-relaxing form endothelial cell surface ACE2 relaxAng IIbalanced Long COVID: spike occupies ACE2, the balance tips spike protein angiotensin II rises endothelial cell surface the balance tips spike blocks ACE2 → angiotensin II rises → vessels constrict & inflame → endothelial dysfunction
Spike protein docks onto ACE2, the same receptor the virus uses to enter cells. With ACE2 occupied and depleted, the protective arm that relaxes vessels falls and angiotensin II rises, tipping the balance toward constriction and inflammation. That tilt is endothelial dysfunction beginning.

What they reveal

Studies report impaired flow-mediated dilation and raised circulating endothelial cells in long COVID, consistent with a damaged, less responsive lining. These are mostly research measures rather than routine clinic tests.1

research-grade

Why it is not yet a clinic test

No single endothelial biomarker is validated to diagnose long COVID or guide its treatment. They strengthen the vascular picture and drive research, but a normal or abnormal result does not yet change individual care.

What we don't know

Honest about the edges of the evidence. These are open questions, not settled answers.

  • Whether any endothelial marker can diagnose long COVID.
  • Whether they predict who recovers.
  • How to standardize the measurements.
  • Whether they can guide vascular treatment.

What this means for you

These tests can show that your vessel lining is affected even when routine results look normal — useful validation — but they remain research-grade, so they rarely change day-to-day care yet. If breathlessness or chest symptoms are your issue, the more practical paths are the cardiopulmonary cluster and the options on improving endothelial function. See endothelial dysfunction for the underlying mechanism.

References

Every reference is free to read in full.

  1. Prolonged endothelial dysfunction in human arterioles months after SARS-CoV-2 (reduced FMD).
  2. Long COVID and ME/CFS show similarly impaired vascular function (Am J Med 2023).

Associated topics

TreatmentImproving endothelial functionmeasures & what's been triedMechanismEndothelial dysfunctionhow it is measured
Journal (0)